Keto, Jaana
Feuth, Thijs
Linna, Miika
Saaresranta, Tarja
Funding for this research was provided by:
Academy of Finland (312703)
Article History
Received: 26 April 2023
Accepted: 30 August 2023
First Online: 8 September 2023
Declarations
:
: The study was carried out as secondary research on pseudonymised health data from which individuals cannot be identified as per the Finnish Act on the Secondary Use of Health and Social Data (552/2019). Findata, the Finnish national data permit authority for the social and health care sector, granted the data permit and did not require an ethics statement or collection of consent. The study was carried out in accordance with relevant guidelines and regulations outlined in the Declaration of Helsinki.
: Not applicable.
: ML: none declared. JK: employee of Jazz Pharmaceuticals. TS: President of the Finnish task Force for the Current Care Guidelines for Adult Sleep Apnoea, personal payment for lectures related to sleep apnea by the Finnish Medical Association, Duodecim, Finnish Society for Specialist in Internal Medicine, Finnish Respiratory Society, Organisation for Respiratory Health in Finland, Chiesi, Jazz Pharmaceuticals, University of Helsinki, Helsinki University Hospital. TF: Personal payment for lectures related to COVID-19 by Pfizer and GSK, and for consulting on pneumonia diagnostics Bio BioMérieux; travel costs by AstraZeneca and GSK.